Patents Assigned to Ontario Institute for Cancer Research
  • Publication number: 20150294062
    Abstract: A method for identifying a target molecular profile associated with a target cell population. A set of reference molecular profiles and a set of sample molecular profiles are received. Each sample molecular profile is associated with a sample cell from a sample cell population, which includes a mixture of target cells and reference cells. Each of the sample molecular profiles is indicative of a respective target molecular profile. An average target molecular profile is calculated. A proportion value is calculated for each sample molecular profile. A respective target molecular profile is calculated for each sample molecular profile based on the respective calculated proportion value and a closest similarity to the average target molecular profile.
    Type: Application
    Filed: October 29, 2013
    Publication date: October 15, 2015
    Applicant: ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR)
    Inventors: Gerald Quon, Syed Haider, Ang Cui, Paul C. Boutros, Quaid D. Morris
  • Publication number: 20140079644
    Abstract: In one aspect, there is provided a compound comprising an acetylated carboxymethylcellulose (CMC-Ac) covalently linked to: at least one poly(ethylene glycol) (PEG), and at least one hydrophobic drug. In another aspect, a self-assembling nanoparticle composition comprising such compounds is provided.
    Type: Application
    Filed: November 19, 2013
    Publication date: March 20, 2014
    Applicant: ONTARIO INSTITUTE FOR CANCER RESEARCH
    Inventors: Shyh-Dar Li, Mark John Ernsting, Wei-Lun Tang
  • Patent number: 8591877
    Abstract: In one aspect, there is provided a compound comprising an acetylated carboxymethylcellulose (CMC-Ac) covalently linked to: at least one poly(ethylene glycol) (PEG), and at least one hydrophobic drug. In another aspect, a self-assembling nanoparticle composition comprising such compounds is provided.
    Type: Grant
    Filed: February 1, 2012
    Date of Patent: November 26, 2013
    Assignee: Ontario Institute for Cancer Research
    Inventors: Shyh-Dar Li, Mark John Ernsting, Wei-Lun Tang